Maria Nagel
Concepts (354)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 72 | 2026 | 336 | 17.530 |
Why?
| | Herpes Zoster | 44 | 2024 | 315 | 10.730 |
Why?
| | Temporal Arteries | 17 | 2021 | 43 | 5.460 |
Why?
| | Giant Cell Arteritis | 13 | 2021 | 46 | 4.940 |
Why?
| | DNA, Viral | 14 | 2024 | 358 | 3.000 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 241 | 2.540 |
Why?
| | Varicella Zoster Virus Infection | 7 | 2026 | 27 | 2.490 |
Why?
| | Cerebral Arteries | 8 | 2021 | 58 | 2.480 |
Why?
| | Encephalitis, Varicella Zoster | 9 | 2016 | 16 | 2.410 |
Why?
| | Virus Diseases | 8 | 2022 | 216 | 2.130 |
Why?
| | Chickenpox | 12 | 2024 | 81 | 2.040 |
Why?
| | Stroke | 10 | 2023 | 1256 | 2.020 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 48 | 1.880 |
Why?
| | Antibodies, Viral | 11 | 2024 | 672 | 1.870 |
Why?
| | Herpesviridae Infections | 7 | 2024 | 150 | 1.860 |
Why?
| | Varicellovirus | 7 | 2024 | 17 | 1.680 |
Why?
| | Virus Activation | 8 | 2026 | 95 | 1.570 |
Why?
| | Astrocytes | 4 | 2020 | 222 | 1.540 |
Why?
| | Herpesvirus 1, Human | 8 | 2026 | 84 | 1.500 |
Why?
| | Adventitia | 5 | 2021 | 43 | 1.450 |
Why?
| | Antiviral Agents | 14 | 2022 | 767 | 1.380 |
Why?
| | Antigens, Viral | 6 | 2021 | 182 | 1.350 |
Why?
| | Vascular Diseases | 6 | 2014 | 251 | 1.330 |
Why?
| | Virus Latency | 9 | 2026 | 90 | 1.310 |
Why?
| | Gene Expression Regulation, Viral | 4 | 2019 | 94 | 1.260 |
Why?
| | Arteritis | 2 | 2021 | 25 | 1.230 |
Why?
| | Fibroblasts | 5 | 2021 | 1034 | 1.160 |
Why?
| | Adrenal Glands | 2 | 2021 | 77 | 1.130 |
Why?
| | Peptide Fragments | 3 | 2024 | 699 | 1.030 |
Why?
| | Exanthema | 6 | 2022 | 84 | 1.010 |
Why?
| | Cerebrovascular Disorders | 3 | 2021 | 103 | 1.010 |
Why?
| | B7-H1 Antigen | 2 | 2019 | 241 | 0.910 |
Why?
| | Ganglia | 4 | 2019 | 18 | 0.840 |
Why?
| | Vasculitis, Central Nervous System | 3 | 2016 | 16 | 0.800 |
Why?
| | Host-Pathogen Interactions | 4 | 2020 | 371 | 0.790 |
Why?
| | Substance P | 2 | 2020 | 39 | 0.790 |
Why?
| | Neuralgia, Postherpetic | 7 | 2014 | 39 | 0.780 |
Why?
| | Immunoglobulin G | 7 | 2024 | 893 | 0.770 |
Why?
| | Optic Neuropathy, Ischemic | 5 | 2015 | 31 | 0.770 |
Why?
| | Nervous System Diseases | 4 | 2016 | 284 | 0.760 |
Why?
| | Humans | 86 | 2026 | 144759 | 0.750 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 9 | 0.670 |
Why?
| | Amyloid | 1 | 2021 | 92 | 0.640 |
Why?
| | Cell Death | 1 | 2022 | 383 | 0.630 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 22 | 0.630 |
Why?
| | Herpes Simplex | 4 | 2026 | 98 | 0.620 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.620 |
Why?
| | Vascular Remodeling | 1 | 2021 | 205 | 0.610 |
Why?
| | Herpes Zoster Ophthalmicus | 2 | 2016 | 6 | 0.600 |
Why?
| | Antigens, CD | 2 | 2019 | 555 | 0.600 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 8 | 0.590 |
Why?
| | Meningitis | 1 | 2020 | 80 | 0.580 |
Why?
| | Matrix Metalloproteinases | 2 | 2019 | 98 | 0.580 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 41 | 0.570 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 8 | 0.570 |
Why?
| | Aged, 80 and over | 17 | 2020 | 8265 | 0.560 |
Why?
| | Cerebral Arterial Diseases | 2 | 2015 | 49 | 0.560 |
Why?
| | Pseudopodia | 1 | 2018 | 27 | 0.560 |
Why?
| | Cells, Cultured | 8 | 2021 | 4154 | 0.560 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 121 | 0.550 |
Why?
| | Myofibroblasts | 1 | 2019 | 143 | 0.550 |
Why?
| | Trigeminal Ganglion | 5 | 2026 | 26 | 0.540 |
Why?
| | Cadherins | 1 | 2019 | 201 | 0.540 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 102 | 0.540 |
Why?
| | Cytokines | 3 | 2024 | 2061 | 0.530 |
Why?
| | Aged | 25 | 2024 | 25913 | 0.510 |
Why?
| | Middle Aged | 27 | 2024 | 35875 | 0.500 |
Why?
| | Burning Mouth Syndrome | 1 | 2016 | 5 | 0.490 |
Why?
| | SUNCT Syndrome | 1 | 2016 | 1 | 0.490 |
Why?
| | Spinal Cord | 2 | 2018 | 380 | 0.480 |
Why?
| | Saliva | 3 | 2016 | 249 | 0.480 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1782 | 0.480 |
Why?
| | Male | 38 | 2024 | 72315 | 0.470 |
Why?
| | Macaca mulatta | 5 | 2024 | 191 | 0.460 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 983 | 0.460 |
Why?
| | Interleukin-6 | 1 | 2019 | 780 | 0.450 |
Why?
| | Vasculitis | 2 | 2015 | 69 | 0.450 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 202 | 0.450 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 917 | 0.440 |
Why?
| | Tunica Intima | 2 | 2012 | 79 | 0.430 |
Why?
| | Acyclovir | 4 | 2020 | 96 | 0.430 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2014 | 13 | 0.430 |
Why?
| | Stellate Ganglion | 1 | 2014 | 6 | 0.420 |
Why?
| | Ganglia, Sympathetic | 1 | 2014 | 14 | 0.420 |
Why?
| | Herpesvirus 2, Human | 1 | 2014 | 27 | 0.420 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 68 | 0.420 |
Why?
| | Steroids | 1 | 2015 | 160 | 0.420 |
Why?
| | Zoster Sine Herpete | 2 | 2012 | 2 | 0.410 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1496 | 0.390 |
Why?
| | Aorta | 1 | 2016 | 429 | 0.380 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 88 | 0.380 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2013 | 53 | 0.380 |
Why?
| | Hippocampus | 1 | 2018 | 965 | 0.380 |
Why?
| | Middle Cerebral Artery | 1 | 2012 | 56 | 0.370 |
Why?
| | Female | 33 | 2024 | 78271 | 0.370 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2608 | 0.370 |
Why?
| | Transcriptome | 3 | 2021 | 1045 | 0.370 |
Why?
| | Gene Expression | 3 | 2020 | 1490 | 0.330 |
Why?
| | Viral Proteins | 6 | 2024 | 355 | 0.320 |
Why?
| | Open Reading Frames | 4 | 2018 | 132 | 0.320 |
Why?
| | Cell Movement | 3 | 2019 | 965 | 0.320 |
Why?
| | RNA, Messenger | 4 | 2020 | 2832 | 0.310 |
Why?
| | RNA, Viral | 4 | 2012 | 688 | 0.310 |
Why?
| | Pemphigus | 1 | 2009 | 8 | 0.300 |
Why?
| | B-Cell Activating Factor | 1 | 2009 | 21 | 0.300 |
Why?
| | Antigens, CD20 | 1 | 2009 | 35 | 0.290 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 442 | 0.290 |
Why?
| | Animals | 21 | 2026 | 38058 | 0.280 |
Why?
| | Primary Cell Culture | 2 | 2022 | 173 | 0.270 |
Why?
| | Inflammation | 5 | 2022 | 2878 | 0.260 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 965 | 0.250 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 1129 | 0.250 |
Why?
| | Alzheimer Disease | 2 | 2023 | 621 | 0.240 |
Why?
| | Retinal Necrosis Syndrome, Acute | 3 | 2013 | 7 | 0.230 |
Why?
| | Extracellular Vesicles | 2 | 2026 | 171 | 0.230 |
Why?
| | Coinfection | 1 | 2026 | 141 | 0.220 |
Why?
| | Adult | 15 | 2024 | 40449 | 0.220 |
Why?
| | Lymphocyte Depletion | 2 | 2019 | 132 | 0.210 |
Why?
| | Brain | 6 | 2024 | 2933 | 0.210 |
Why?
| | Leukocytes | 2 | 2018 | 295 | 0.210 |
Why?
| | Neurodegenerative Diseases | 1 | 2026 | 151 | 0.210 |
Why?
| | Virus Replication | 3 | 2022 | 529 | 0.200 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 1098 | 0.190 |
Why?
| | Monkey Diseases | 2 | 2024 | 25 | 0.190 |
Why?
| | Biopsy | 2 | 2016 | 1075 | 0.180 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.180 |
Why?
| | Adrenal Cortex | 1 | 2022 | 33 | 0.180 |
Why?
| | B-Lymphocytes | 3 | 2013 | 876 | 0.180 |
Why?
| | Microglia | 1 | 2024 | 268 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 7 | 2016 | 3863 | 0.180 |
Why?
| | Exosomes | 1 | 2023 | 104 | 0.180 |
Why?
| | Tissue Fixation | 1 | 2021 | 36 | 0.170 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1519 | 0.170 |
Why?
| | Paraffin Embedding | 1 | 2021 | 32 | 0.170 |
Why?
| | Electrophoresis, Capillary | 2 | 2013 | 19 | 0.170 |
Why?
| | Macaca fascicularis | 1 | 2021 | 71 | 0.170 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 98 | 0.170 |
Why?
| | Histological Techniques | 1 | 2021 | 38 | 0.170 |
Why?
| | Autoantibodies | 1 | 2009 | 1501 | 0.170 |
Why?
| | Formaldehyde | 1 | 2021 | 66 | 0.170 |
Why?
| | Plasma | 1 | 2023 | 225 | 0.170 |
Why?
| | Risk Factors | 5 | 2021 | 10779 | 0.170 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 846 | 0.170 |
Why?
| | Cerebral Angiography | 2 | 2012 | 119 | 0.170 |
Why?
| | DNA, Complementary | 1 | 2021 | 276 | 0.160 |
Why?
| | Cell Line | 4 | 2020 | 2882 | 0.160 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 42 | 0.160 |
Why?
| | Skin | 2 | 2019 | 755 | 0.160 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 9 | 0.160 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 75 | 0.160 |
Why?
| | Interleukins | 1 | 2022 | 248 | 0.160 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 76 | 0.160 |
Why?
| | Intracellular Space | 1 | 2020 | 66 | 0.150 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 474 | 0.150 |
Why?
| | Claudin-1 | 1 | 2019 | 15 | 0.150 |
Why?
| | Extracellular Space | 1 | 2020 | 120 | 0.150 |
Why?
| | Protein Aggregates | 1 | 2020 | 86 | 0.150 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 111 | 0.150 |
Why?
| | Tacrolimus | 1 | 2020 | 196 | 0.150 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 14 | 0.150 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 29 | 0.150 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 44 | 0.150 |
Why?
| | Prevalence | 3 | 2015 | 2834 | 0.150 |
Why?
| | Spinal Cord Diseases | 2 | 2010 | 41 | 0.150 |
Why?
| | Thrombosis | 1 | 2023 | 393 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2020 | 3604 | 0.150 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 99 | 0.150 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 4 | 0.140 |
Why?
| | Spiro Compounds | 1 | 2018 | 17 | 0.140 |
Why?
| | Diagnosis, Differential | 3 | 2013 | 1489 | 0.140 |
Why?
| | Macrophages | 3 | 2024 | 1511 | 0.140 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 55 | 0.140 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 104 | 0.140 |
Why?
| | Coculture Techniques | 1 | 2019 | 246 | 0.140 |
Why?
| | DNA | 3 | 2021 | 1463 | 0.140 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 124 | 0.140 |
Why?
| | Risk | 1 | 2020 | 911 | 0.130 |
Why?
| | Motor Neurons | 1 | 2020 | 234 | 0.130 |
Why?
| | Herpes Zoster Vaccine | 2 | 2011 | 154 | 0.130 |
Why?
| | Fatal Outcome | 2 | 2015 | 307 | 0.130 |
Why?
| | Aortic Diseases | 1 | 2018 | 124 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 478 | 0.130 |
Why?
| | Protein Isoforms | 1 | 2018 | 402 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 264 | 0.120 |
Why?
| | Aortitis | 1 | 2016 | 10 | 0.120 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 405 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 573 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 341 | 0.120 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5992 | 0.120 |
Why?
| | Virology | 2 | 2013 | 36 | 0.120 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2015 | 22 | 0.120 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2015 | 27 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2015 | 56 | 0.110 |
Why?
| | Neuroglia | 1 | 2016 | 172 | 0.110 |
Why?
| | Histocytochemistry | 1 | 2015 | 79 | 0.110 |
Why?
| | Eye Infections, Viral | 1 | 2015 | 12 | 0.110 |
Why?
| | Pheochromocytoma | 1 | 2016 | 58 | 0.110 |
Why?
| | Functional Laterality | 1 | 2016 | 241 | 0.110 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2015 | 132 | 0.110 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2016 | 91 | 0.110 |
Why?
| | STAT2 Transcription Factor | 1 | 2014 | 3 | 0.110 |
Why?
| | Oxygen | 1 | 2020 | 995 | 0.110 |
Why?
| | Neurons | 2 | 2016 | 1640 | 0.110 |
Why?
| | Down-Regulation | 1 | 2016 | 627 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2023 | 1241 | 0.100 |
Why?
| | Internationality | 1 | 2015 | 156 | 0.100 |
Why?
| | Vision Disorders | 2 | 2012 | 178 | 0.100 |
Why?
| | Interferon-beta | 1 | 2014 | 92 | 0.100 |
Why?
| | Medulla Oblongata | 1 | 2013 | 37 | 0.100 |
Why?
| | Fluorometry | 1 | 2013 | 18 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 64 | 0.100 |
Why?
| | Pons | 1 | 2013 | 33 | 0.100 |
Why?
| | Age Factors | 2 | 2014 | 3333 | 0.100 |
Why?
| | Risk Assessment | 1 | 2023 | 3671 | 0.100 |
Why?
| | Interferon-alpha | 1 | 2014 | 197 | 0.100 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 654 | 0.100 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 103 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 39 | 0.100 |
Why?
| | Blood Vessels | 1 | 2014 | 171 | 0.100 |
Why?
| | Myelitis | 1 | 2014 | 107 | 0.090 |
Why?
| | Dementia, Multi-Infarct | 1 | 2012 | 1 | 0.090 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 375 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1054 | 0.090 |
Why?
| | Protein Transport | 1 | 2014 | 441 | 0.090 |
Why?
| | Methylprednisolone | 1 | 2012 | 64 | 0.090 |
Why?
| | Optic Nerve | 1 | 2012 | 67 | 0.090 |
Why?
| | Apoptosis | 2 | 2019 | 2430 | 0.090 |
Why?
| | RNA | 1 | 2019 | 940 | 0.090 |
Why?
| | Nanoparticles | 1 | 2018 | 519 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1716 | 0.090 |
Why?
| | Facial Paralysis | 1 | 2011 | 23 | 0.090 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 49 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2496 | 0.080 |
Why?
| | Hyperplasia | 1 | 2011 | 174 | 0.080 |
Why?
| | Fetus | 1 | 2015 | 803 | 0.080 |
Why?
| | MicroRNAs | 2 | 2024 | 701 | 0.080 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 88 | 0.080 |
Why?
| | Myosin Heavy Chains | 1 | 2011 | 185 | 0.080 |
Why?
| | Herpes Zoster Oticus | 1 | 2010 | 2 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1047 | 0.080 |
Why?
| | RNA Stability | 1 | 2011 | 119 | 0.080 |
Why?
| | Immunocompromised Host | 1 | 2011 | 201 | 0.080 |
Why?
| | Phosphorylation | 1 | 2014 | 1732 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1658 | 0.080 |
Why?
| | Cranial Nerve Diseases | 1 | 2010 | 43 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 22428 | 0.070 |
Why?
| | Receptors, CCR1 | 1 | 2009 | 4 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 266 | 0.070 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2009 | 3 | 0.070 |
Why?
| | Neural Stem Cells | 1 | 2011 | 166 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4271 | 0.070 |
Why?
| | Actins | 1 | 2011 | 425 | 0.070 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 97 | 0.070 |
Why?
| | Lung | 3 | 2019 | 4109 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2947 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 109 | 0.070 |
Why?
| | History, 21st Century | 1 | 2009 | 219 | 0.070 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 168 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 325 | 0.070 |
Why?
| | Rituximab | 1 | 2009 | 209 | 0.070 |
Why?
| | DNA Primers | 1 | 2009 | 512 | 0.070 |
Why?
| | Pain | 1 | 2012 | 779 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2190 | 0.060 |
Why?
| | Chickenpox Vaccine | 1 | 2007 | 75 | 0.060 |
Why?
| | Neutrophils | 1 | 2012 | 1134 | 0.060 |
Why?
| | Spinal Cord Ischemia | 1 | 2007 | 60 | 0.060 |
Why?
| | Antidepressive Agents | 1 | 2008 | 248 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2930 | 0.060 |
Why?
| | Incidence | 1 | 2013 | 2879 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 2115 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 228 | 0.060 |
Why?
| | Time Factors | 3 | 2014 | 7173 | 0.050 |
Why?
| | Registries | 1 | 2014 | 2385 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4557 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1094 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1982 | 0.050 |
Why?
| | Disease Progression | 4 | 2014 | 2847 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1985 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5868 | 0.050 |
Why?
| | Recurrence | 2 | 2021 | 1135 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 101 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 2050 | 0.050 |
Why?
| | Presenilin-1 | 1 | 2022 | 33 | 0.050 |
Why?
| | Mice | 4 | 2024 | 18339 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Central Nervous System | 1 | 2024 | 281 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2730 | 0.050 |
Why?
| | Fructose | 1 | 2023 | 130 | 0.050 |
Why?
| | Uric Acid | 1 | 2023 | 166 | 0.040 |
Why?
| | Olfactory Bulb | 1 | 2022 | 97 | 0.040 |
Why?
| | Young Adult | 2 | 2024 | 14105 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 5226 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 187 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 1143 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 247 | 0.040 |
Why?
| | Neuroimaging | 1 | 2021 | 289 | 0.040 |
Why?
| | Infant | 2 | 2024 | 10034 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 262 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2018 | 327 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11787 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1047 | 0.030 |
Why?
| | Plasmids | 1 | 2018 | 379 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 276 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 185 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 506 | 0.030 |
Why?
| | Child | 3 | 2024 | 22633 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 502 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2182 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1195 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1253 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 499 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 126 | 0.020 |
Why?
| | Mitochondria | 1 | 2020 | 984 | 0.020 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2012 | 3 | 0.020 |
Why?
| | Apraxias | 1 | 2012 | 6 | 0.020 |
Why?
| | Dysarthria | 1 | 2012 | 10 | 0.020 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2012 | 10 | 0.020 |
Why?
| | Pupil Disorders | 1 | 2012 | 7 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 406 | 0.020 |
Why?
| | Postmortem Changes | 1 | 2012 | 17 | 0.020 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 48 | 0.020 |
Why?
| | Valine | 1 | 2012 | 80 | 0.020 |
Why?
| | Visual Acuity | 1 | 2015 | 489 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 45 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2012 | 266 | 0.020 |
Why?
| | Thiouridine | 1 | 2011 | 1 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 16 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 221 | 0.020 |
Why?
| | Phosphonoacetic Acid | 1 | 2011 | 10 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Memory Disorders | 1 | 2012 | 193 | 0.020 |
Why?
| | Thalamus | 1 | 2012 | 125 | 0.020 |
Why?
| | Half-Life | 1 | 2011 | 151 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 251 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 370 | 0.020 |
Why?
| | Alphaherpesvirinae | 1 | 2009 | 1 | 0.020 |
Why?
| | Vero Cells | 1 | 2009 | 84 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1047 | 0.020 |
Why?
| | Immunization | 1 | 2011 | 374 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1030 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 707 | 0.020 |
Why?
| | HeLa Cells | 1 | 2009 | 650 | 0.020 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2007 | 44 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 67 | 0.020 |
Why?
| | Treatment Failure | 1 | 2007 | 365 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1813 | 0.010 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2007 | 154 | 0.010 |
Why?
| | Arteries | 1 | 2007 | 259 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3540 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2875 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4089 | 0.010 |
Why?
|
|
Nagel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|